Cargando…
SAR-CoV-2 infection, emerging new variants and the role of activation induced cytidine deaminase (AID) in lasting immunity
As the world faces a fourth COVID-19 spike, scientists are learning a lot more about the new SARS-CoV-2 strains that were previously unknown. Currently, the Delta versions of SARS-CoV-2 have become the prevalent strains in much of the world since it first appeared in India in late 2020. Researchers...
Autores principales: | Ullah, Asad, Mabood, Neelam, Maqbool, Muhammad, Khan, Luqman, Khan, Maria, Ullah, Mujib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452370/ https://www.ncbi.nlm.nih.gov/pubmed/34566457 http://dx.doi.org/10.1016/j.jsps.2021.09.006 |
Ejemplares similares
-
Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target
por: Ullah, Asad, et al.
Publicado: (2021) -
Human APOBEC1 cytidine deaminase edits HBV DNA
por: Gonzalez, Minerva Cervantes, et al.
Publicado: (2009) -
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer
por: Mechtcheriakova, Diana, et al.
Publicado: (2012) -
AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates
por: Liu, Mei-Chen, et al.
Publicado: (2018) -
COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities
por: Khan, Luqman, et al.
Publicado: (2020)